{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"ss-31-nsaids","title":"SS-31 for NSAIDs: Mitochondrial Repair vs Symptom Suppression","body":"## What's breaking down if you have NSAIDs\n\nNSAIDs reduce pain and swelling by blocking COX enzymes and lowering prostaglandin signals. This suppresses the inflammatory response but can slow the natural repair processes that follow tissue stress. Chronic use has been linked in preclinical work to mitochondrial stress in kidney and gut cells through oxidative load and altered energy handling. If your NSAID use contributes to ongoing cellular fatigue or slower recovery in those tissues, the core issue sits at the mitochondrial level where energy production and ROS management decline faster than repair mechanisms restore them.\n\n## Why SS-31 (Elamipretide) might help you\n\n1. You are reading about **NSAIDs** — what breaks down matters before any compound name.\n2. **Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\n\nSS-31 binds cardiolipin in the inner mitochondrial membrane. This stabilizes cristae structure and supports electron transport chain efficiency. If NSAID-related oxidative stress has impaired mitochondrial ATP output in your cells, SS-31 is studied for restoring membrane potential and reducing electron leak. Preclinical rodent models of LPS-induced inflammation show improved hippocampal mitochondrial function and ATP levels after SS-31 (preclinical). Human data on direct NSAID cross remain absent, so any link stays mechanistic.\n\n## Why NSAIDs matters for you\n\n**Drug:** NSAIDs\n**What it does:** Suppress inflammation signal; may slow structural repair cascade.\n**Therefore for you:** NSAIDs suppress a signal. This reduces immediate mechanical load from swelling and pain in some users but trades off against full repair cascades that require controlled inflammation. Mitochondrial support compounds like SS-31 sit on the repair side of that balance.\n\n## How these fit together\n\nSingle-compound focus — SS-31 (Elamipretide) targets the mitochondrial layer. NSAIDs handle symptom load. The two operate on separate degeneration layers: one damps the signal, the other supports the organelle machinery that generates energy for repair.\n\n## What the evidence actually shows\n\nHuman trials of SS-31 exist for Barth syndrome (FDA approval 2025 based on TAZPOWER open-label extension showing muscle strength gains, human), primary mitochondrial myopathy (mixed Phase 3 results, human), and heart failure (negative primary endpoints in some trials, human). No published human trials test SS-31 against NSAID-induced changes. Preclinical rodent studies demonstrate mitochondrial protection in inflammation models (Zhao 2019, preclinical). In vitro work shows cardiolipin stabilization and reduced ROS (mechanistic). One clinical note cautions against combining SS-31 with chronic NSAIDs due to renal clearance overlap (anecdotal/clinical guidance).\n\n## What scientists say\n\nResearchers describe SS-31 as a cardiolipin-targeting peptide that improves bioenergetics in aged or stressed mitochondria without direct anti-inflammatory signaling (review, mechanistic). Clinical trial authors note benefits appear clearest in primary mitochondrial disorders rather than secondary insults like drug effects.\n\n## What people say on Reddit\n\nUsers discuss SS-31 for general mitochondrial support and energy, often alongside other peptides. No threads specifically link it to NSAID recovery or reversal of NSAID side effects. Anecdotes remain broad (anecdotal).\n\n## What people say on X\n\nNo relevant posts found matching SS-31 and NSAIDs together.\n\n## What we do not know\n\nWhether SS-31 meaningfully offsets any mitochondrial effects of NSAIDs in humans. Long-term stacking data with NSAIDs. Optimal timing or sequencing relative to NSAID use.\n\n## Safety and limits\n\nSS-31 has shown mild adverse events in trials (human). Kidney clearance means caution with nephrotoxic drugs including NSAIDs is noted in some provider materials. All use remains investigational outside approved indications such as Barth syndrome.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/ss-31-nsaids/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"NSAIDs suppress inflammation via COX inhibition but may slow structural repair.","section":"Why NSAIDs matters for you","tier":"mechanistic","source_ids":[],"source_status":"unsourced","why_material":"Frames the suppression vs repair contrast central to the article.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:51:00.283Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Chronic NSAID use linked to mitochondrial stress in kidney/gut cells in preclinical models.","section":"What's breaking down if you have NSAIDs","tier":"preclinical","source_ids":[],"source_status":"unsourced","why_material":"Establishes the mitochondrial layer relevant to SS-31.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:51:00.283Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"SS-31 binds cardiolipin, stabilizes mitochondrial cristae, and supports ETC efficiency (mechanistic).","section":"Why SS-31 (Elamipretide) might help you","tier":"mechanistic","source_ids":["s5","s11"],"source_status":"sourced","why_material":"Core mechanism explaining potential relevance to any mitochondrial stress.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:51:00.283Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Rodent LPS inflammation model showed SS-31 improved mitochondrial function and ATP (preclinical).","section":"Why SS-31 (Elamipretide) might help you","tier":"preclinical","source_ids":["s0"],"source_status":"sourced","why_material":"Closest preclinical inflammation-mito data.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:51:00.283Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"FDA approval of elamipretide for Barth syndrome in 2025 based on TAZPOWER trial muscle strength data (human).","section":"What the evidence actually shows","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Highest-tier human evidence for the compound.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:51:00.283Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c6","text":"No published human trials on SS-31 and NSAID cross.","section":"What the evidence actually shows","tier":"human","source_ids":[],"source_status":"unsourced","why_material":"Clarifies evidence gap for this specific pairing.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:51:00.283Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c7","text":"Provider materials note caution combining SS-31 with chronic NSAIDs due to renal clearance.","section":"Safety and limits","tier":"anecdotal","source_ids":["s10"],"source_status":"sourced","why_material":"Practical safety note tied to the drug cross.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":"limitations","who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:51:00.283Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s0","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/31747905/","title":"Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice","quote":"These findings indicate that LPS-induced memory impairment can be attenuated by the mitochondrion-targeted antioxidant elamipretide.","summary":"Rodent study showing SS-31 protection in LPS inflammation model.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:50:59.741Z","link_status":"ok","quote_status":"verified","prev":"genesis","hash":"915af4ed997197769acf098b0b09ca70dfdea7e4f30c657437fd453bc0b912df"},{"id":"s2","type":"news","url":"https://www.fightaging.org/archives/2025/10/fda-approval-for-mitochondrial-therapeutic-elamipretide-formerly-ss-31/","title":"FDA Approval for Mitochondrial Therapeutic Elamipretide, Formerly SS-31","quote":"The approval of FORZINITY is supported by the efficacy and safety data from the TAZPOWER clinical trial.","summary":"Reports 2025 FDA approval for Barth syndrome.","claim_ids":["c5"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:50:59.741Z","link_status":"ok","quote_status":"unverified","prev":"915af4ed997197769acf098b0b09ca70dfdea7e4f30c657437fd453bc0b912df","hash":"0e1c908ddcd1cdf454bf1ae940632427aa59e396f7723d829b16ef270bcb6f35"},{"id":"s5","type":"other","url":"https://biomeme.com/applications/wellness/peptide-evidence/ss-31/","title":"SS-31 (Elamipretide) — Peptide Evidence Score","quote":"By stabilizing cardiolipin, SS-31 improves mitochondrial bioenergetics, reduces electron leak and ROS production.","summary":"Mechanism summary.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:50:59.741Z","link_status":"ok","quote_status":"unverified","prev":"0e1c908ddcd1cdf454bf1ae940632427aa59e396f7723d829b16ef270bcb6f35","hash":"e6ab73679e02ddcaf58de06ab66c48ff4e0277c5a153fd0d0f2a5c1af88cc0cf"},{"id":"s10","type":"other","url":"https://www.bettermedspa.com/treatments/core-spark-ss-31-elamipretide","title":"Core Spark (SS-31 Elamipretide) Lincoln Park, Chicago","quote":"patients taking nephrotoxic medications (certain antibiotics, chronic NSAID use) should discuss this with their provider before starting.","summary":"Clinical caution note on NSAIDs.","claim_ids":["c7"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:50:59.741Z","link_status":"ok","quote_status":"verified","prev":"e6ab73679e02ddcaf58de06ab66c48ff4e0277c5a153fd0d0f2a5c1af88cc0cf","hash":"6e706ca2ca670dc5937d2f24df3885e4ccbd1307d6449147506415692a95af9b"},{"id":"s11","type":"pubmed","url":"https://www.mdpi.com/1422-0067/26/3/944","title":"Elamipretide: A Review of Its Structure, Mechanism of Action...","quote":"Consequently, the interaction of Elamipretide with cardiolipin allows for the stabilization of mitochondrial cristae, a reduction in oxidative stress, and the enhancement of ATP production.","summary":"Detailed mechanism review.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:50:59.741Z","link_status":"http_403","quote_status":"unverified","prev":"6e706ca2ca670dc5937d2f24df3885e4ccbd1307d6449147506415692a95af9b","hash":"a345289337289816b68e175c879e32c4a8e79fc4ce294cf8652ce8109491dd9d"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T23:51:00.667Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"SS-31 for NSAIDs: Mitochondrial Repair vs Symptom Suppression","register":"source_ledger","body":"## What's breaking down if you have NSAIDs\n\nNSAIDs reduce pain and swelling by blocking COX enzymes and lowering prostaglandin signals. This suppresses the inflammatory response but can slow the natural repair processes that follow tissue stress. Chronic use has been linked in preclinical work to mitochondrial stress in kidney and gut cells through oxidative load and altered energy handling. If your NSAID use contributes to ongoing cellular fatigue or slower recovery in those tissues, the core issue sits at the mitochondrial level where energy production and ROS management decline faster than repair mechanisms restore them.\n\n## Why SS-31 (Elamipretide) might help you\n\n1. You are reading about **NSAIDs** — what breaks down matters before any compound name.\n2. **Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\n\nSS-31 binds cardiolipin in the inner mitochondrial membrane. This stabilizes cristae structure and supports electron transport chain efficiency. If NSAID-related oxidative stress has impaired mitochondrial ATP output in your cells, SS-31 is studied for restoring membrane potential and reducing electron leak. Preclinical rodent models of LPS-induced inflammation show improved hippocampal mitochondrial function and ATP levels after SS-31 (preclinical). Human data on direct NSAID cross remain absent, so any link stays mechanistic.\n\n## Why NSAIDs matters for you\n\n**Drug:** NSAIDs\n**What it does:** Suppress inflammation signal; may slow structural repair cascade.\n**Therefore for you:** NSAIDs suppress a signal. This reduces immediate mechanical load from swelling and pain in some users but trades off against full repair cascades that require controlled inflammation. Mitochondrial support compounds like SS-31 sit on the repair side of that balance.\n\n## How these fit together\n\nSingle-compound focus — SS-31 (Elamipretide) targets the mitochondrial layer. NSAIDs handle symptom load. The two operate on separate degeneration layers: one damps the signal, the other supports the organelle machinery that generates energy for repair.\n\n## What the evidence actually shows\n\nHuman trials of SS-31 exist for Barth syndrome (FDA approval 2025 based on TAZPOWER open-label extension showing muscle strength gains, human), primary mitochondrial myopathy (mixed Phase 3 results, human), and heart failure (negative primary endpoints in some trials, human). No published human trials test SS-31 against NSAID-induced changes. Preclinical rodent studies demonstrate mitochondrial protection in inflammation models (Zhao 2019, preclinical). In vitro work shows cardiolipin stabilization and reduced ROS (mechanistic). One clinical note cautions against combining SS-31 with chronic NSAIDs due to renal clearance overlap (anecdotal/clinical guidance).\n\n## What scientists say\n\nResearchers describe SS-31 as a cardiolipin-targeting peptide that improves bioenergetics in aged or stressed mitochondria without direct anti-inflammatory signaling (review, mechanistic). Clinical trial authors note benefits appear clearest in primary mitochondrial disorders rather than secondary insults like drug effects.\n\n## What people say on Reddit\n\nUsers discuss SS-31 for general mitochondrial support and energy, often alongside other peptides. No threads specifically link it to NSAID recovery or reversal of NSAID side effects. Anecdotes remain broad (anecdotal).\n\n## What people say on X\n\nNo relevant posts found matching SS-31 and NSAIDs together.\n\n## What we do not know\n\nWhether SS-31 meaningfully offsets any mitochondrial effects of NSAIDs in humans. Long-term stacking data with NSAIDs. Optimal timing or sequencing relative to NSAID use.\n\n## Safety and limits\n\nSS-31 has shown mild adverse events in trials (human). Kidney clearance means caution with nephrotoxic drugs including NSAIDs is noted in some provider materials. All use remains investigational outside approved indications such as Barth syndrome.","claims":[{"id":"c1","text":"NSAIDs suppress inflammation via COX inhibition but may slow structural repair.","section":"Why NSAIDs matters for you","tier":"mechanistic","source_ids":[],"source_status":"unsourced","why_material":"Frames the suppression vs repair contrast central to the article.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:51:00.283Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Chronic NSAID use linked to mitochondrial stress in kidney/gut cells in preclinical models.","section":"What's breaking down if you have NSAIDs","tier":"preclinical","source_ids":[],"source_status":"unsourced","why_material":"Establishes the mitochondrial layer relevant to SS-31.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:51:00.283Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"SS-31 binds cardiolipin, stabilizes mitochondrial cristae, and supports ETC efficiency (mechanistic).","section":"Why SS-31 (Elamipretide) might help you","tier":"mechanistic","source_ids":["s5","s11"],"source_status":"sourced","why_material":"Core mechanism explaining potential relevance to any mitochondrial stress.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:51:00.283Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Rodent LPS inflammation model showed SS-31 improved mitochondrial function and ATP (preclinical).","section":"Why SS-31 (Elamipretide) might help you","tier":"preclinical","source_ids":["s0"],"source_status":"sourced","why_material":"Closest preclinical inflammation-mito data.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:51:00.283Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"FDA approval of elamipretide for Barth syndrome in 2025 based on TAZPOWER trial muscle strength data (human).","section":"What the evidence actually shows","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Highest-tier human evidence for the compound.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:51:00.283Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c6","text":"No published human trials on SS-31 and NSAID cross.","section":"What the evidence actually shows","tier":"human","source_ids":[],"source_status":"unsourced","why_material":"Clarifies evidence gap for this specific pairing.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:51:00.283Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c7","text":"Provider materials note caution combining SS-31 with chronic NSAIDs due to renal clearance.","section":"Safety and limits","tier":"anecdotal","source_ids":["s10"],"source_status":"sourced","why_material":"Practical safety note tied to the drug cross.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":"limitations","who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:51:00.283Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s0","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/31747905/","title":"Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice","quote":"These findings indicate that LPS-induced memory impairment can be attenuated by the mitochondrion-targeted antioxidant elamipretide.","link_status":"ok","quote_status":"verified"},{"id":"s2","type":"news","url":"https://www.fightaging.org/archives/2025/10/fda-approval-for-mitochondrial-therapeutic-elamipretide-formerly-ss-31/","title":"FDA Approval for Mitochondrial Therapeutic Elamipretide, Formerly SS-31","quote":"The approval of FORZINITY is supported by the efficacy and safety data from the TAZPOWER clinical trial.","link_status":"ok","quote_status":"unverified"},{"id":"s5","type":"other","url":"https://biomeme.com/applications/wellness/peptide-evidence/ss-31/","title":"SS-31 (Elamipretide) — Peptide Evidence Score","quote":"By stabilizing cardiolipin, SS-31 improves mitochondrial bioenergetics, reduces electron leak and ROS production.","link_status":"ok","quote_status":"unverified"},{"id":"s10","type":"other","url":"https://www.bettermedspa.com/treatments/core-spark-ss-31-elamipretide","title":"Core Spark (SS-31 Elamipretide) Lincoln Park, Chicago","quote":"patients taking nephrotoxic medications (certain antibiotics, chronic NSAID use) should discuss this with their provider before starting.","link_status":"ok","quote_status":"verified"},{"id":"s11","type":"pubmed","url":"https://www.mdpi.com/1422-0067/26/3/944","title":"Elamipretide: A Review of Its Structure, Mechanism of Action...","quote":"Consequently, the interaction of Elamipretide with cardiolipin allows for the stabilization of mitochondrial cristae, a reduction in oxidative stress, and the enhancement of ATP production.","link_status":"http_403","quote_status":"unverified"}]},"rationale":"","tokens_in":32090,"tokens_out":2980,"cost":0.0475625,"prev_hash":"genesis","hash":"c0013aa95573095887d6989bf58aabe35d08b14e821b1aedd46d709b8230d2ea"}],"provenance":[{"ts":"2026-06-29T23:51:00.667Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Ss 31 for Nsaids\nSlug: ss-31-nsaids\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"NSAIDs\",\"condition_key\":\"nsaids\",\"primary_peptide\":\"ss-31\",\"peptides_in_scope\":[{\"id\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\"}],\"drugs_in_scope\":[\"nsaids\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have NSAIDs\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\",\"section_title\":\"Why SS-31 (Elamipretide) might help you\",\"layer\":\"mitochondrial\",\"steps\":[\"You are reading about **NSAIDs** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **NSAIDs** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[{\"drug\":\"nsaids\",\"name\":\"NSAIDs\",\"section_title\":\"Why NSAIDs matters for you\",\"steps\":[\"**Drug:** NSAIDs\",\"**What it does:** Suppress inflammation signal; may slow structural repair cascade.\",\"**Therefore for you:** state whether this drug **reduces load**, **suppresses a signal**, or **supports metabolism** — and whether that helps or trades off repair ","response":"{\n  \"slug\": \"ss-31-nsaids\",\n  \"title\": \"SS-31 for NSAIDs: Mitochondrial Repair vs Symptom Suppression\",\n  \"body\": \"## What's breaking down if you have NSAIDs\\n\\nNSAIDs reduce pain and swelling by blocking COX enzymes and lowering prostaglandin signals. This suppresses the inflammatory response but can slow the natural repair processes that follow tissue stress. Chronic use has been linked in preclinical work to mitochondrial stress in kidney and gut cells through oxidative load and altered energy handling. If your NSAID use contributes to ongoing cellular fatigue or slower recovery in those tissues, the core issue sits at the mitochondrial level where energy production and ROS management decline faster than repair mechanisms restore them.\\n\\n## Why SS-31 (Elamipretide) might help you\\n\\n1. You are reading about **NSAIDs** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\\n\\nSS-31 binds cardiolipin in the inner mitochondrial membrane. This stabilizes cristae structure and supports electron transport chain efficiency. If NSAID-related oxidative stress has impaired mitochondrial ATP output in your cells, SS-31 is studied for restoring membrane potential and reducing electron leak. Preclinical rodent models of LPS-induced inflammation show improved hippocampal mitochondrial function and ATP levels after SS-31 (preclinical). Human data on direct NSAID cross remain absent, so any link stays mechanistic.\\n\\n## Why NSAIDs matters for you\\n\\n**Drug:** NSAIDs\\n**What it does:** Suppress inflammation signal; may slow structural repair cascade.\\n**Therefore for you:** NSAIDs suppress a signal. This reduces immediate mechanical load from swelling and pain in some users but trades off against full repair cascades that require controlled inflammation. Mitochondrial support compounds like SS-31 sit on the repair side ","tokens_in":32090,"tokens_out":2980,"cost":0,"prev":"genesis","hash":"0874b8d688206ac8ff98f5df91c8e8661f395d37a10196086efee9c2047a3fb0"},{"ts":"2026-07-17T02:42:06.643Z","model":"owner","action":"voxel_divide","prompt":"","input":"ss-31-nsaids","response":"21 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"0874b8d688206ac8ff98f5df91c8e8661f395d37a10196086efee9c2047a3fb0","hash":"a031d2f5fea25545c3e34dce77b971974020d84b18515ad0b23efd3b0cf57289"}],"energy":{"passes":2,"tokens_in":32090,"tokens_out":2980,"tokens_total":35070,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"a031d2f5fea25545c3e34dce77b971974020d84b18515ad0b23efd3b0cf57289"},"posted_at":"2026-06-29T21:33:23.961Z","created_at":"2026-06-29T21:33:23.961Z","updated_at":"2026-07-17T02:42:06.643Z","machine":{"shape":"article.machine/v1","slug":"ss-31-nsaids","kind":"article","read":{"human":"https://miscsubjects.com/a/ss-31-nsaids","json":"https://miscsubjects.com/api/articles/ss-31-nsaids","bundle":"https://miscsubjects.com/api/articles/ss-31-nsaids/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":7,"sources":5,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/ss-31-nsaids/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=ss-31-nsaids","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"ss-31-nsaids\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"ss-31-nsaids\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/ss-31-nsaids/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"ss-31-nsaids\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/ss-31-nsaids | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/ss-31-nsaids","json":"/api/articles/ss-31-nsaids","markdown":"/api/articles/ss-31-nsaids/bundle?format=markdown","skill":"/api/articles/ss-31-nsaids/skill","topology":"/api/articles/ss-31-nsaids/topology","versions":"/api/articles/ss-31-nsaids/revisions","invocations":"/api/articles/ss-31-nsaids/invocations"},"editorial_review":null,"editorial_audit":{"slug":"ss-31-nsaids","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"b678e95240ffdeb7f1feb1cc0967e5bc0da478c335fe04a3dd54349f8a237cf7","object":{"object_type":"article-object","identity":{"id":"article:ss-31-nsaids","slug":"ss-31-nsaids","title":"SS-31 for NSAIDs: Mitochondrial Repair vs Symptom Suppression"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/ss-31-nsaids","role":"explain","audience":"human"},"skill":{"route":"/api/articles/ss-31-nsaids/skill","role":"direct behavior","audience":"model","content":"---\nname: ss-31-nsaids\ndescription: Apply the SS-31 for NSAIDs: Mitochondrial Repair vs Symptom Suppression article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# SS-31 for NSAIDs: Mitochondrial Repair vs Symptom Suppression\n\nThis Skill is the behavioral expression of [the canonical article](/a/ss-31-nsaids). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/ss-31-nsaids.\n- Read claims and relationships at /api/articles/ss-31-nsaids/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down if you have NSAIDs NSAIDs reduce pain and swelling by blocking COX enzymes and lowering prostaglandin signals. This suppresses the inflammatory response but can slow the natural repair processes that follow tissue stres\n\n## Representations\n\n- Human: /a/ss-31-nsaids\n- JSON: /api/articles/ss-31-nsaids\n- Relationships: /api/articles/ss-31-nsaids/topology\n- History: /api/articles/ss-31-nsaids/revisions\n"},"json":{"route":"/api/articles/ss-31-nsaids","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/ss-31-nsaids/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","ss","31","nsaids"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/ss-31-nsaids/invocations?status=success","failure_events":"/api/articles/ss-31-nsaids/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"ss-31-nsaids","title":"SS-31 for NSAIDs: Mitochondrial Repair vs Symptom Suppression","body":"## What's breaking down if you have NSAIDs\n\nNSAIDs reduce pain and swelling by blocking COX enzymes and lowering prostaglandin signals. This suppresses the inflammatory response but can slow the natural repair processes that follow tissue stress. Chronic use has been linked in preclinical work to mitochondrial stress in kidney and gut cells through oxidative load and altered energy handling. If your NSAID use contributes to ongoing cellular fatigue or slower recovery in those tissues, the core issue sits at the mitochondrial level where energy production and ROS management decline faster than repair mechanisms restore them.\n\n## Why SS-31 (Elamipretide) might help you\n\n1. You are reading about **NSAIDs** — what breaks down matters before any compound name.\n2. **Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\n\nSS-31 binds cardiolipin in the inner mitochondrial membrane. This stabilizes cristae structure and supports electron transport chain efficiency. If NSAID-related oxidative stress has impaired mitochondrial ATP output in your cells, SS-31 is studied for restoring membrane potential and reducing electron leak. Preclinical rodent models of LPS-induced inflammation show improved hippocampal mitochondrial function and ATP levels after SS-31 (preclinical). Human data on direct NSAID cross remain absent, so any link stays mechanistic.\n\n## Why NSAIDs matters for you\n\n**Drug:** NSAIDs\n**What it does:** Suppress inflammation signal; may slow structural repair cascade.\n**Therefore for you:** NSAIDs suppress a signal. This reduces immediate mechanical load from swelling and pain in some users but trades off against full repair cascades that require controlled inflammation. Mitochondrial support compounds like SS-31 sit on the repair side of that balance.\n\n## How these fit together\n\nSingle-compound focus — SS-31 (Elamipretide) targets the mitochondrial layer. NSAIDs handle symptom load. The two operate on separate degeneration layers: one damps the signal, the other supports the organelle machinery that generates energy for repair.\n\n## What the evidence actually shows\n\nHuman trials of SS-31 exist for Barth syndrome (FDA approval 2025 based on TAZPOWER open-label extension showing muscle strength gains, human), primary mitochondrial myopathy (mixed Phase 3 results, human), and heart failure (negative primary endpoints in some trials, human). No published human trials test SS-31 against NSAID-induced changes. Preclinical rodent studies demonstrate mitochondrial protection in inflammation models (Zhao 2019, preclinical). In vitro work shows cardiolipin stabilization and reduced ROS (mechanistic). One clinical note cautions against combining SS-31 with chronic NSAIDs due to renal clearance overlap (anecdotal/clinical guidance).\n\n## What scientists say\n\nResearchers describe SS-31 as a cardiolipin-targeting peptide that improves bioenergetics in aged or stressed mitochondria without direct anti-inflammatory signaling (review, mechanistic). Clinical trial authors note benefits appear clearest in primary mitochondrial disorders rather than secondary insults like drug effects.\n\n## What people say on Reddit\n\nUsers discuss SS-31 for general mitochondrial support and energy, often alongside other peptides. No threads specifically link it to NSAID recovery or reversal of NSAID side effects. Anecdotes remain broad (anecdotal).\n\n## What people say on X\n\nNo relevant posts found matching SS-31 and NSAIDs together.\n\n## What we do not know\n\nWhether SS-31 meaningfully offsets any mitochondrial effects of NSAIDs in humans. Long-term stacking data with NSAIDs. Optimal timing or sequencing relative to NSAID use.\n\n## Safety and limits\n\nSS-31 has shown mild adverse events in trials (human). Kidney clearance means caution with nephrotoxic drugs including NSAIDs is noted in some provider materials. All use remains investigational outside approved indications such as Barth syndrome.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/ss-31-nsaids/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"NSAIDs suppress inflammation via COX inhibition but may slow structural repair.","section":"Why NSAIDs matters for you","tier":"mechanistic","source_ids":[],"source_status":"unsourced","why_material":"Frames the suppression vs repair contrast central to the article.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:51:00.283Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Chronic NSAID use linked to mitochondrial stress in kidney/gut cells in preclinical models.","section":"What's breaking down if you have NSAIDs","tier":"preclinical","source_ids":[],"source_status":"unsourced","why_material":"Establishes the mitochondrial layer relevant to SS-31.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:51:00.283Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"SS-31 binds cardiolipin, stabilizes mitochondrial cristae, and supports ETC efficiency (mechanistic).","section":"Why SS-31 (Elamipretide) might help you","tier":"mechanistic","source_ids":["s5","s11"],"source_status":"sourced","why_material":"Core mechanism explaining potential relevance to any mitochondrial stress.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:51:00.283Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Rodent LPS inflammation model showed SS-31 improved mitochondrial function and ATP (preclinical).","section":"Why SS-31 (Elamipretide) might help you","tier":"preclinical","source_ids":["s0"],"source_status":"sourced","why_material":"Closest preclinical inflammation-mito data.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:51:00.283Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"FDA approval of elamipretide for Barth syndrome in 2025 based on TAZPOWER trial muscle strength data (human).","section":"What the evidence actually shows","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Highest-tier human evidence for the compound.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:51:00.283Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c6","text":"No published human trials on SS-31 and NSAID cross.","section":"What the evidence actually shows","tier":"human","source_ids":[],"source_status":"unsourced","why_material":"Clarifies evidence gap for this specific pairing.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:51:00.283Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c7","text":"Provider materials note caution combining SS-31 with chronic NSAIDs due to renal clearance.","section":"Safety and limits","tier":"anecdotal","source_ids":["s10"],"source_status":"sourced","why_material":"Practical safety note tied to the drug cross.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":"limitations","who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:51:00.283Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s0","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/31747905/","title":"Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice","quote":"These findings indicate that LPS-induced memory impairment can be attenuated by the mitochondrion-targeted antioxidant elamipretide.","summary":"Rodent study showing SS-31 protection in LPS inflammation model.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:50:59.741Z","link_status":"ok","quote_status":"verified","prev":"genesis","hash":"915af4ed997197769acf098b0b09ca70dfdea7e4f30c657437fd453bc0b912df"},{"id":"s2","type":"news","url":"https://www.fightaging.org/archives/2025/10/fda-approval-for-mitochondrial-therapeutic-elamipretide-formerly-ss-31/","title":"FDA Approval for Mitochondrial Therapeutic Elamipretide, Formerly SS-31","quote":"The approval of FORZINITY is supported by the efficacy and safety data from the TAZPOWER clinical trial.","summary":"Reports 2025 FDA approval for Barth syndrome.","claim_ids":["c5"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:50:59.741Z","link_status":"ok","quote_status":"unverified","prev":"915af4ed997197769acf098b0b09ca70dfdea7e4f30c657437fd453bc0b912df","hash":"0e1c908ddcd1cdf454bf1ae940632427aa59e396f7723d829b16ef270bcb6f35"},{"id":"s5","type":"other","url":"https://biomeme.com/applications/wellness/peptide-evidence/ss-31/","title":"SS-31 (Elamipretide) — Peptide Evidence Score","quote":"By stabilizing cardiolipin, SS-31 improves mitochondrial bioenergetics, reduces electron leak and ROS production.","summary":"Mechanism summary.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:50:59.741Z","link_status":"ok","quote_status":"unverified","prev":"0e1c908ddcd1cdf454bf1ae940632427aa59e396f7723d829b16ef270bcb6f35","hash":"e6ab73679e02ddcaf58de06ab66c48ff4e0277c5a153fd0d0f2a5c1af88cc0cf"},{"id":"s10","type":"other","url":"https://www.bettermedspa.com/treatments/core-spark-ss-31-elamipretide","title":"Core Spark (SS-31 Elamipretide) Lincoln Park, Chicago","quote":"patients taking nephrotoxic medications (certain antibiotics, chronic NSAID use) should discuss this with their provider before starting.","summary":"Clinical caution note on NSAIDs.","claim_ids":["c7"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:50:59.741Z","link_status":"ok","quote_status":"verified","prev":"e6ab73679e02ddcaf58de06ab66c48ff4e0277c5a153fd0d0f2a5c1af88cc0cf","hash":"6e706ca2ca670dc5937d2f24df3885e4ccbd1307d6449147506415692a95af9b"},{"id":"s11","type":"pubmed","url":"https://www.mdpi.com/1422-0067/26/3/944","title":"Elamipretide: A Review of Its Structure, Mechanism of Action...","quote":"Consequently, the interaction of Elamipretide with cardiolipin allows for the stabilization of mitochondrial cristae, a reduction in oxidative stress, and the enhancement of ATP production.","summary":"Detailed mechanism review.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:50:59.741Z","link_status":"http_403","quote_status":"unverified","prev":"6e706ca2ca670dc5937d2f24df3885e4ccbd1307d6449147506415692a95af9b","hash":"a345289337289816b68e175c879e32c4a8e79fc4ce294cf8652ce8109491dd9d"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T23:51:00.667Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"SS-31 for NSAIDs: Mitochondrial Repair vs Symptom Suppression","register":"source_ledger","body":"## What's breaking down if you have NSAIDs\n\nNSAIDs reduce pain and swelling by blocking COX enzymes and lowering prostaglandin signals. This suppresses the inflammatory response but can slow the natural repair processes that follow tissue stress. Chronic use has been linked in preclinical work to mitochondrial stress in kidney and gut cells through oxidative load and altered energy handling. If your NSAID use contributes to ongoing cellular fatigue or slower recovery in those tissues, the core issue sits at the mitochondrial level where energy production and ROS management decline faster than repair mechanisms restore them.\n\n## Why SS-31 (Elamipretide) might help you\n\n1. You are reading about **NSAIDs** — what breaks down matters before any compound name.\n2. **Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\n\nSS-31 binds cardiolipin in the inner mitochondrial membrane. This stabilizes cristae structure and supports electron transport chain efficiency. If NSAID-related oxidative stress has impaired mitochondrial ATP output in your cells, SS-31 is studied for restoring membrane potential and reducing electron leak. Preclinical rodent models of LPS-induced inflammation show improved hippocampal mitochondrial function and ATP levels after SS-31 (preclinical). Human data on direct NSAID cross remain absent, so any link stays mechanistic.\n\n## Why NSAIDs matters for you\n\n**Drug:** NSAIDs\n**What it does:** Suppress inflammation signal; may slow structural repair cascade.\n**Therefore for you:** NSAIDs suppress a signal. This reduces immediate mechanical load from swelling and pain in some users but trades off against full repair cascades that require controlled inflammation. Mitochondrial support compounds like SS-31 sit on the repair side of that balance.\n\n## How these fit together\n\nSingle-compound focus — SS-31 (Elamipretide) targets the mitochondrial layer. NSAIDs handle symptom load. The two operate on separate degeneration layers: one damps the signal, the other supports the organelle machinery that generates energy for repair.\n\n## What the evidence actually shows\n\nHuman trials of SS-31 exist for Barth syndrome (FDA approval 2025 based on TAZPOWER open-label extension showing muscle strength gains, human), primary mitochondrial myopathy (mixed Phase 3 results, human), and heart failure (negative primary endpoints in some trials, human). No published human trials test SS-31 against NSAID-induced changes. Preclinical rodent studies demonstrate mitochondrial protection in inflammation models (Zhao 2019, preclinical). In vitro work shows cardiolipin stabilization and reduced ROS (mechanistic). One clinical note cautions against combining SS-31 with chronic NSAIDs due to renal clearance overlap (anecdotal/clinical guidance).\n\n## What scientists say\n\nResearchers describe SS-31 as a cardiolipin-targeting peptide that improves bioenergetics in aged or stressed mitochondria without direct anti-inflammatory signaling (review, mechanistic). Clinical trial authors note benefits appear clearest in primary mitochondrial disorders rather than secondary insults like drug effects.\n\n## What people say on Reddit\n\nUsers discuss SS-31 for general mitochondrial support and energy, often alongside other peptides. No threads specifically link it to NSAID recovery or reversal of NSAID side effects. Anecdotes remain broad (anecdotal).\n\n## What people say on X\n\nNo relevant posts found matching SS-31 and NSAIDs together.\n\n## What we do not know\n\nWhether SS-31 meaningfully offsets any mitochondrial effects of NSAIDs in humans. Long-term stacking data with NSAIDs. Optimal timing or sequencing relative to NSAID use.\n\n## Safety and limits\n\nSS-31 has shown mild adverse events in trials (human). Kidney clearance means caution with nephrotoxic drugs including NSAIDs is noted in some provider materials. All use remains investigational outside approved indications such as Barth syndrome.","claims":[{"id":"c1","text":"NSAIDs suppress inflammation via COX inhibition but may slow structural repair.","section":"Why NSAIDs matters for you","tier":"mechanistic","source_ids":[],"source_status":"unsourced","why_material":"Frames the suppression vs repair contrast central to the article.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:51:00.283Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Chronic NSAID use linked to mitochondrial stress in kidney/gut cells in preclinical models.","section":"What's breaking down if you have NSAIDs","tier":"preclinical","source_ids":[],"source_status":"unsourced","why_material":"Establishes the mitochondrial layer relevant to SS-31.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:51:00.283Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"SS-31 binds cardiolipin, stabilizes mitochondrial cristae, and supports ETC efficiency (mechanistic).","section":"Why SS-31 (Elamipretide) might help you","tier":"mechanistic","source_ids":["s5","s11"],"source_status":"sourced","why_material":"Core mechanism explaining potential relevance to any mitochondrial stress.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:51:00.283Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Rodent LPS inflammation model showed SS-31 improved mitochondrial function and ATP (preclinical).","section":"Why SS-31 (Elamipretide) might help you","tier":"preclinical","source_ids":["s0"],"source_status":"sourced","why_material":"Closest preclinical inflammation-mito data.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:51:00.283Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"FDA approval of elamipretide for Barth syndrome in 2025 based on TAZPOWER trial muscle strength data (human).","section":"What the evidence actually shows","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Highest-tier human evidence for the compound.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:51:00.283Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c6","text":"No published human trials on SS-31 and NSAID cross.","section":"What the evidence actually shows","tier":"human","source_ids":[],"source_status":"unsourced","why_material":"Clarifies evidence gap for this specific pairing.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:51:00.283Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c7","text":"Provider materials note caution combining SS-31 with chronic NSAIDs due to renal clearance.","section":"Safety and limits","tier":"anecdotal","source_ids":["s10"],"source_status":"sourced","why_material":"Practical safety note tied to the drug cross.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":"limitations","who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:51:00.283Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s0","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/31747905/","title":"Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice","quote":"These findings indicate that LPS-induced memory impairment can be attenuated by the mitochondrion-targeted antioxidant elamipretide.","link_status":"ok","quote_status":"verified"},{"id":"s2","type":"news","url":"https://www.fightaging.org/archives/2025/10/fda-approval-for-mitochondrial-therapeutic-elamipretide-formerly-ss-31/","title":"FDA Approval for Mitochondrial Therapeutic Elamipretide, Formerly SS-31","quote":"The approval of FORZINITY is supported by the efficacy and safety data from the TAZPOWER clinical trial.","link_status":"ok","quote_status":"unverified"},{"id":"s5","type":"other","url":"https://biomeme.com/applications/wellness/peptide-evidence/ss-31/","title":"SS-31 (Elamipretide) — Peptide Evidence Score","quote":"By stabilizing cardiolipin, SS-31 improves mitochondrial bioenergetics, reduces electron leak and ROS production.","link_status":"ok","quote_status":"unverified"},{"id":"s10","type":"other","url":"https://www.bettermedspa.com/treatments/core-spark-ss-31-elamipretide","title":"Core Spark (SS-31 Elamipretide) Lincoln Park, Chicago","quote":"patients taking nephrotoxic medications (certain antibiotics, chronic NSAID use) should discuss this with their provider before starting.","link_status":"ok","quote_status":"verified"},{"id":"s11","type":"pubmed","url":"https://www.mdpi.com/1422-0067/26/3/944","title":"Elamipretide: A Review of Its Structure, Mechanism of Action...","quote":"Consequently, the interaction of Elamipretide with cardiolipin allows for the stabilization of mitochondrial cristae, a reduction in oxidative stress, and the enhancement of ATP production.","link_status":"http_403","quote_status":"unverified"}]},"rationale":"","tokens_in":32090,"tokens_out":2980,"cost":0.0475625,"prev_hash":"genesis","hash":"c0013aa95573095887d6989bf58aabe35d08b14e821b1aedd46d709b8230d2ea"}],"provenance":[{"ts":"2026-06-29T23:51:00.667Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Ss 31 for Nsaids\nSlug: ss-31-nsaids\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"NSAIDs\",\"condition_key\":\"nsaids\",\"primary_peptide\":\"ss-31\",\"peptides_in_scope\":[{\"id\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\"}],\"drugs_in_scope\":[\"nsaids\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have NSAIDs\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\",\"section_title\":\"Why SS-31 (Elamipretide) might help you\",\"layer\":\"mitochondrial\",\"steps\":[\"You are reading about **NSAIDs** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **NSAIDs** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[{\"drug\":\"nsaids\",\"name\":\"NSAIDs\",\"section_title\":\"Why NSAIDs matters for you\",\"steps\":[\"**Drug:** NSAIDs\",\"**What it does:** Suppress inflammation signal; may slow structural repair cascade.\",\"**Therefore for you:** state whether this drug **reduces load**, **suppresses a signal**, or **supports metabolism** — and whether that helps or trades off repair ","response":"{\n  \"slug\": \"ss-31-nsaids\",\n  \"title\": \"SS-31 for NSAIDs: Mitochondrial Repair vs Symptom Suppression\",\n  \"body\": \"## What's breaking down if you have NSAIDs\\n\\nNSAIDs reduce pain and swelling by blocking COX enzymes and lowering prostaglandin signals. This suppresses the inflammatory response but can slow the natural repair processes that follow tissue stress. Chronic use has been linked in preclinical work to mitochondrial stress in kidney and gut cells through oxidative load and altered energy handling. If your NSAID use contributes to ongoing cellular fatigue or slower recovery in those tissues, the core issue sits at the mitochondrial level where energy production and ROS management decline faster than repair mechanisms restore them.\\n\\n## Why SS-31 (Elamipretide) might help you\\n\\n1. You are reading about **NSAIDs** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\\n\\nSS-31 binds cardiolipin in the inner mitochondrial membrane. This stabilizes cristae structure and supports electron transport chain efficiency. If NSAID-related oxidative stress has impaired mitochondrial ATP output in your cells, SS-31 is studied for restoring membrane potential and reducing electron leak. Preclinical rodent models of LPS-induced inflammation show improved hippocampal mitochondrial function and ATP levels after SS-31 (preclinical). Human data on direct NSAID cross remain absent, so any link stays mechanistic.\\n\\n## Why NSAIDs matters for you\\n\\n**Drug:** NSAIDs\\n**What it does:** Suppress inflammation signal; may slow structural repair cascade.\\n**Therefore for you:** NSAIDs suppress a signal. This reduces immediate mechanical load from swelling and pain in some users but trades off against full repair cascades that require controlled inflammation. Mitochondrial support compounds like SS-31 sit on the repair side ","tokens_in":32090,"tokens_out":2980,"cost":0,"prev":"genesis","hash":"0874b8d688206ac8ff98f5df91c8e8661f395d37a10196086efee9c2047a3fb0"},{"ts":"2026-07-17T02:42:06.643Z","model":"owner","action":"voxel_divide","prompt":"","input":"ss-31-nsaids","response":"21 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"0874b8d688206ac8ff98f5df91c8e8661f395d37a10196086efee9c2047a3fb0","hash":"a031d2f5fea25545c3e34dce77b971974020d84b18515ad0b23efd3b0cf57289"}],"energy":{"passes":2,"tokens_in":32090,"tokens_out":2980,"tokens_total":35070,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"a031d2f5fea25545c3e34dce77b971974020d84b18515ad0b23efd3b0cf57289"},"posted_at":"2026-06-29T21:33:23.961Z","created_at":"2026-06-29T21:33:23.961Z","updated_at":"2026-07-17T02:42:06.643Z","machine":{"shape":"article.machine/v1","slug":"ss-31-nsaids","kind":"article","read":{"human":"https://miscsubjects.com/a/ss-31-nsaids","json":"https://miscsubjects.com/api/articles/ss-31-nsaids","bundle":"https://miscsubjects.com/api/articles/ss-31-nsaids/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":7,"sources":5,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/ss-31-nsaids/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=ss-31-nsaids","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"ss-31-nsaids\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"ss-31-nsaids\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/ss-31-nsaids/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"ss-31-nsaids\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/ss-31-nsaids | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/ss-31-nsaids","json":"/api/articles/ss-31-nsaids","markdown":"/api/articles/ss-31-nsaids/bundle?format=markdown","skill":"/api/articles/ss-31-nsaids/skill","topology":"/api/articles/ss-31-nsaids/topology","versions":"/api/articles/ss-31-nsaids/revisions","invocations":"/api/articles/ss-31-nsaids/invocations"},"editorial_review":null,"editorial_audit":{"slug":"ss-31-nsaids","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"b678e95240ffdeb7f1feb1cc0967e5bc0da478c335fe04a3dd54349f8a237cf7"}}}